Truist Securities Reiterates Hold Rating on AnaptysBio (ANAB)
Tweet Send to a Friend
Truist Securities analyst John Lee reiterated a Hold rating and $30.00 price target on AnaptysBio (NASDAQ: ANAB).The analyst commented, "ANAB ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


